Rigel Raises $31.5M To Move First Product Into Clinic In 2002

Jan. 18, 2002

By Brady Huggett

Maxim Begins Ceplene Phase III With Liver Metastases Patients

Jan. 18, 2002

By Brady Huggett

Rigel Raises $31.5M To Move First Product Into Clinic In 2002

Jan. 18, 2002

By Brady Huggett

Immunex’s Enbrel Continues Growth, Receives 4th Approval

Jan. 17, 2002

By Brady Huggett

Immunex’s Enbrel Continues Growth, Receives 4th Approval

Jan. 17, 2002

By Brady Huggett

Aderis Files For $100M IPO With Parkinson’s Product In Phase III

Jan. 15, 2002

By Brady Huggett

Aderis Files For $100M IPO With Parkinson’s Product In Phase III

Jan. 15, 2002

By Brady Huggett

Antigenics Raises $60M From Shelf For Oncophage Trials

Jan. 14, 2002

By Brady Huggett

Antigenics Raises $60M From Shelf For Oncophage Trials

Jan. 14, 2002

By Brady Huggett

Hyseq Buying Amgen Compound To Move First Product Into Clinic

Jan. 10, 2002

By Brady Huggett